CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Daiichi Sankyo to give commercial team a makeover; Novo Nordisk's GPCR partner finds CMO

Neutral
AI Analysis

Summary

Daiichi Sankyo will restructure its commercial organization with Ken Keller as chief commercialization officer, effective April 1, 2027. Novo Nordisk has found a CMO for its GPCR partner program.

Importance:2/10
Sentiment:
0.00
commercial_reorganizationmanagement_changeorganizational_restructuring
Related Companies

Read the original article

Published by Endpoints News on August 28, 2026 11:00 AM

Read Original